Reactions 1680, p102 - 2 Dec 2017 Cyclophosphamide/doxorubicin/ paclitaxel Vitiligo: case report A woman in her 50s [exact age at reaction onset not stated] developed vitiligo during treatment with cyclophosphamide, doxorubicin [adriamycin] and paclitaxel. The woman had a history of hypothyroidism treated with thyroxine replacement therapy. She was diagnosed with breast cancer along with an axillary lymphadenopathy at the age of 58 years, and underwent left modified radical mastectomy. Subsequently, she received 4 cycles of chemotherapy with 2 2 cyclophosphamide 600 mg/m and doxorubicin 60 mg/m , followed by four cycles of paclitaxel 175 mg/m [routes not stated]. After completion of 24 week chemotherapy course, she was treated with an external beam radiotherapy to the left chest wall. Approximately nine months after radiotherapy, she was observed with a depigmentation on the left chest wall, which was congruent with area of radiation delivery. The hypopigmented lesions could be identified with sharp margins. The lesions were without a definite shape, which coalesced and persisted as evidenced in her successive follow- ups. At the last follow up, the woman was found to be well, though continued with hypopigmented lesions on the left chest, without any further regression or progression. Author comment: "It is not clear whether addition of chemotherapy contributed to the development of hypopigmentation, but it was likely a risk factor." Pavithran K, et al. Report of a case of radiation-induced new-onset vitiligo with collective review of cases in the literature of radiation-related vitiligo. Case Reports in Medicine 2013: 2013. Available from: URL: http:// doi.org/10.1155/2013/345473 - India 803284146 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680
Reactions Weekly – Springer Journals
Published: Dec 2, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera